Stéphane Budel, DeciBio | Precision medicine is our future and our fate | TPM podcast #46

from Talking Precision Medicine · host Genialis

Stéphane Budel, founding partner at DeciBio, joins the Talking Precision Medicine Podcast to explore the future of the field. He unpacks how liquid biopsy, multi-omics, and AI are opening new doors for personalized care, why the diagnostics business model is holding innovation back, and what it will take to make complex tech usable for clinicians and patients alike.⁠TPM E46 highlights >⁠⁠⁠⁠⁠⁠⁠⁠Episode 46 links:DeciBioStephane Budel on LinkedInDeciBio’s White Paper on AI in Drug Development (with contributions from Rafael Rosengarten)

Episode metadata supplied by the publisher feed · Published May 19, 2025

Embed this episode

Attribution link and audio player

Ready to play

Stéphane Budel, DeciBio | Precision medicine is our future and our fate | TPM podcast #46

0:00 50:02

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Talking Precision Medicine?

This episode is 50 minutes long.

When was this Talking Precision Medicine episode published?

This episode was published on May 19, 2025.

Can I download this Talking Precision Medicine episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!